The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

This form of the disease is caused by abnormal blood vessels growing through the retinal pigment epithelium and damaging the macula. Dry age-related macular degeneration is more common and caused ...

Macular degeneration, also known as age-related macular degeneration ... Macular degeneration occurs as cells within the retinal pigment epithelium (RPE) degrade and die. The RPE is a layer ...

The research team led by Dr. Moon-Hyeong Seo from the Natural Product Drug Development Center at the Korea Institute of ...

This could be a sign of age-related macular ... onset retinal degeneration messes up your entire field of vision, while AMD mainly affects the center. Most people with AMD have the dry form ...

Dec. 3, 2024 – A research team co-led by the University of California, Irvine has discovered that accumulated DNA damage in the retina is a key contributor to age-related macular degeneration ...

This vision loss is the result of damage to the macula, a part of the retina. You can learn ... about your risk of developing macular degeneration here. Dry age-related macular degeneration ...

Digging deeper, at least eight million people face total blindness from age-related macular degeneration ... the breakdown of the retinal layer called the retina pigment epithelium.

Opens in a new tab or window Obstructive sleep apnea (OSA) was linked to a more than twofold risk of developing age-related macular degeneration (AMD) in a retrospective cohort study. Among 58,700 ...

Opens in a new tab or window GA lesions, which form on the retina due to degeneration of pigment epithelium ... GA, the advanced form of dry age-related macular degeneration (AMD), poses a ...

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular edema ...